These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26654248)

  • 1. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.
    Simmons RD; Kirwan P; Beebeejaun K; Riordan A; Borrow R; Ramsay ME; Delpech V; Lattimore S; Ladhani S
    BMC Med; 2015 Dec; 13():297. PubMed ID: 26654248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated risk for invasive meningococcal disease among persons with HIV.
    Miller L; Arakaki L; Ramautar A; Bodach S; Braunstein SL; Kennedy J; Steiner-Sichel L; Ngai S; Shepard C; Weiss D
    Ann Intern Med; 2014 Jan; 160(1):30-7. PubMed ID: 24166695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine.
    Mandal S; Campbell H; Ribeiro S; Gray S; Carr T; White J; Ladhani SN; Ramsay ME
    Vaccine; 2017 Oct; 35(43):5814-5818. PubMed ID: 28928076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016.
    Meiring S; Cohen C; de Gouveia L; du Plessis M; Kularatne R; Hoosen A; Lekalakala R; Lengana S; Seetharam S; Naicker P; Quan V; Reubenson G; Tempia S; von Mollendorf C; von Gottberg A;
    Clin Infect Dis; 2019 Jul; 69(3):495-504. PubMed ID: 30351372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015.
    Parikh SR; Campbell H; Gray SJ; Beebeejaun K; Ribeiro S; Borrow R; Ramsay ME; Ladhani SN
    Vaccine; 2018 Jun; 36(26):3876-3881. PubMed ID: 29699791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City.
    Simon MS; Weiss D; Geevarughese A; Kratz MM; Cutler B; Gulick RM; Zucker JR; Varma JK; Schackman BR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):146-54. PubMed ID: 26334735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
    Hellenbrand W; Koch J; Harder T; Bogdan C; Heininger U; Tenenbaum T; Terhardt M; Vogel U; Wichmann O; von Kries R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1314-43. PubMed ID: 26487381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    Parent du Chatelet I; Deghmane AE; Antona D; Hong E; Fonteneau L; Taha MK; Lévy-Bruhl D
    J Infect; 2017 Jun; 74(6):564-574. PubMed ID: 28279715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal infections among refugees and immigrants: silent threats of past, present and future.
    Dinleyici EC; Borrow R
    Hum Vaccin Immunother; 2020 Nov; 16(11):2781-2786. PubMed ID: 32347773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower risk of invasive meningococcal disease during pregnancy: national prospective surveillance in England, 2011-2014.
    Parikh SR; Borrow R; Ramsay ME; Ladhani SN
    BJOG; 2019 Jul; 126(8):1052-1057. PubMed ID: 30932328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).
    Ladhani SN; Campbell H; Lucidarme J; Gray S; Parikh S; Willerton L; Clark SA; Lekshmi A; Walker A; Patel S; Bai X; Ramsay M; Borrow R
    BMC Infect Dis; 2019 Jun; 19(1):522. PubMed ID: 31200658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive meningococcal disease in older adults: current perspectives and call for action.
    Weil-Olivier C; Taha MK; Leng S; Dinleyici EC; Bonanni P; Moya E; Leischker A; Yezli S
    Eur Geriatr Med; 2024 Jun; 15(3):729-741. PubMed ID: 38709380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine strategies of meningococcal disease: results of a 10-year population-based study.
    Biebl A; Hartmann G; Bernhard C; Bechter E; Luckner-Hornischer A; Frühwirth M; Heuberger S; Offner F; Barbieri V; Simma B
    Eur J Pediatr; 2005 Dec; 164(12):735-40. PubMed ID: 16133244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults.
    Lundbo LF; Harboe ZB; Sandholdt H; Smith-Hansen L; Valentiner-Branth P; Hoffmann S; Benfield T
    Clin Infect Dis; 2022 Aug; 75(1):125-130. PubMed ID: 34569601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    De Wals P; Deceuninck G; Lefebvre B; Tsang R; Law D; De Serres G; Gilca V; Gilca R; Boulianne N
    Clin Infect Dis; 2017 May; 64(9):1263-1267. PubMed ID: 28207068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.